Influence of anti-TNF-α treatment on liver and kidney functions in patients with ankylosing spondylitis: A retrospective longitudinal study
Main Authors: | Lütfi Akyol, Mehmet Ali Balcı |
---|---|
Format: | Article |
Language: | English |
Published: |
AVES
2022-01-01
|
Series: | European Journal of Rheumatology |
Online Access: | https://www.eurjrheumatol.org/en/influence-of-anti-tnf-treatment-on-liver-and-kidney-functions-in-patients-with-ankylosing-spondylitis-a-retrospective-longitudinal-study-133410 |
Similar Items
-
Recommendations for starting anti TNF-α in patients with ankylosing spondylitis
by: L. Olivieri, et al.
Published: (2003-12-01) -
Anti-TNF treatment in ankylosing spondylitis patients with chronic kidney disease: Is it effective and safe?
by: Belkıs Nihan Coşkun, et al.
Published: (2022-04-01) -
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs
by: F.M. Perrotta, et al.
Published: (2014-11-01) -
Response to anti-TNF-α treatment for secondary renal amyloidosis in a patient with ankylosing spondylitis
by: A. Gallo, et al.
Published: (2011-09-01) -
Associations of Platelet Count with Inflammation and Response to Anti-TNF-α Therapy in Patients with Ankylosing Spondylitis
by: Hongyan Qian, et al.
Published: (2020-11-01)